Steven Gillis - Director at Q32 Bio Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
QTTB on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Steven Gillis since 14 Aug 2025

Reported holdings for Steven Gillis in Q32 Bio Inc.

Form 4 holding Director

Homology Medicines, Inc.

Security class
Option (Right to Buy)
Shares / value
23,000
Estimated value
$308,660
Report date
14 Jun 2023
Price
$13.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Steven Gillis in Q32 Bio Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .